KBC Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
KBC Group's XERS Position: Q3 2026 in Review
KBC Group held its Xeris Biopharma Holdings (XERS) position steady in Q3 2026 at 4,573 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #1753.
KBC Group first reported a position in XERS in Q1 2026 and has held it in 3 quarters since. 210 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- KBC Group held 4,573 shares of Xeris Biopharma Holdings worth $44K as of Q3 2026.
- KBC Group left its Xeris Biopharma Holdings share count unchanged in Q3 2026.
- Xeris Biopharma Holdings made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1753 holding.
- KBC Group first reported a position in Xeris Biopharma Holdings in Q1 2026 and has held it in 3 quarters since.
- 210 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.